Menu

Image of the Day: Cellular Destiny

Progenitor cells in the pancreas of humans get developmental cues from proteins in their environment.

Dec 11, 2018
Carolyn Wilke
An embryonic pancreatic bud that was grown ex vivo from human cells
DANSTEM

R

esearchers have cracked the code that guides immature human pancreatic cells to their destiny. The results of this study, published in Nature on November 28, could help scientists direct stem cells to grow into the insulin-producing ones for potential use in replacement therapy for type 1 diabetes.

The researchers attached pancreatic progenitor cells, which are similar to stem cells but have a limited capacity to replicate, to a glass slide that was covered in different types of proteins. They could then watch how the cells reacted to the proteins without the interference of neighbor cells. They also observed mechanical force changes inside each cell that cued its development. Specifically, the protein laminin prodded progenitor cells into becoming endocrine cells, such as the insulin-producing beta cell, by reducing their mechanical force. 

These results provide the tools “to more precisely engineer cells that are lost or damaged in severe diseases, such as type 1 diabetes and neurodegenerative diseases, for future cell replacement therapies,” study author Henrick Semb says in a statement.

A. Mamidi, et al., “Mechanosignalling via integrins directs fate decisions of pancreatic progenitors,” Naturedoi:10.1038/s41586-018-0762-2, 2018.

June 2019

Living with Bacteria

Can pathogens be converted to commensals?

Marketplace

Sponsored Product Updates

New-Generation Incubator Brings the Latest Technology to Mid-Capacity Microplate Cell Culture
New-Generation Incubator Brings the Latest Technology to Mid-Capacity Microplate Cell Culture
New Thermo Scientific Cytomat 2 C-LiN Series Automated Incubator delivers robust and reliable culture solution for cell-based pharmaceutical applications
Cellecta, Inc. Launches the First Commercially Available Dual-sgRNA Libraries for CRISPRa and CRISPRi Genetic Screens
Cellecta, Inc. Launches the First Commercially Available Dual-sgRNA Libraries for CRISPRa and CRISPRi Genetic Screens
Libraries of pooled lentiviral constructs that express two different sgRNA to all 19,000 human protein-coding genes improve overall gene activation or repression and generate more robust screening results
Novel Antibody-Drug Conjugates: Characterization Tools and Formulation/Process Development
Novel Antibody-Drug Conjugates: Characterization Tools and Formulation/Process Development
In this webinar, learn about antibody-drug conjugates (ADCs) and their function, how to analyze and characterize ADCs, and developing ADC processes and formulations.
Sartorius debuts the Intellicyt iQue3 at CYTO® 2019
Sartorius debuts the Intellicyt iQue3 at CYTO® 2019
Sartorius will be showcasing the latest addition to its cellular analysis portfolio on booth #103 at this year’s CYTO® conference and exhibition, with the launch of the Intellicyt iQue3.